The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer
Open accessAbstract
The peroxisome proliferator–activated receptor γ (PPARγ) is highly expressed in the colon mucosa and its activation has been reported to protect against colitis. We studied the involvement of PPARγ and its heterodimeric partner, the retinoid X receptor (RXR) in intestinal inflammatory responses. PPARγ1/− and RXRα1/− mice both displayed a significantly enhanced susceptibility to 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis compared with their wild-type littermates. A role for the RXR/PPARγ heterodimer in the protection against colon inflammation was explored by the use of selective RXR and PPARγ agonists. TNBS-induced colitis was significantly reduced by the administration of both PPARγ and RXR agonists. This beneficial effect was reflected by increased survival rates, an improvement of macroscopic and histologic scores, a decrease in tumor necrosis factor α and interleukin 1β mRNA levels, a diminished myeloperoxidase concentration, and reduction of nuclear factor κB DNA binding activity, c-Jun NH2-terminal kinase, and p38 activities in the colon. When coadministered, a significant synergistic effect of PPARγ and RXR ligands was observed. In combination, these data demonstrate that activation of the RXR/PPARγ heterodimer protects against colon inflammation and suggest that combination therapy with both RXR and PPARγ ligands might hold promise in the clinic due to their synergistic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationPeroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Self-citationPPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · cited 1×
“scription factor (ATF)2(1-109), 50 mM ATP, and 3–10 mCi of [g-32P]ATP as substrates in 20 ml of kinase buffer (20).”
BackgroundThe Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Self-citationChawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069 · cited 2×
“scription factor (ATF)2(1-109), 50 mM ATP, and 3–10 mCi of [g-32P]ATP as substrates in 20 ml of kinase buffer (20).”
BackgroundNeurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
Su, C. G., Wen, X., Bailey, S. T., Jiang, W., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., & Wu, G. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7145 · Cited by 767
Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway
Lee, F. S., Hagler, J., Chen, Z. J., & Maniatis, T. (1997) · Cell · doi:10.1016/s0092-8674(00)81842-5 · Cited by 707
Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 697
Self-citationA Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675
Lefebvre, A.-M., Chen, I., Desreumaux, P., Najib, J., Fruchart, J.-C., Geboes, K., Briggs, M., Heyman, R., & Auwerx, J. (1998) · Nature Medicine · doi:10.1038/2036 · Cited by 611
Self-citationNakano, H., Shindo, M., Sakon, S., Nishinaka, S., Mihara, M., Yagita, H., & Okumura, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3537 · Cited by 517
The role of PPAR-γ in macrophage differentiation and cholesterol uptake
Moore, K. J., Rosen, E. D., Fitzgerald, M. L., Randow, F., Andersson, L. P., Altshuler, D., Milstone, D. S., Mortensen, R. M., Spiegelman, B. M., & Freeman, M. W. (2001) · Nature Medicine · doi:10.1038/83328 · Cited by 513
Peroxisome proliterator-activated receptors, orphans with ligands and functions
Schoonjans, K., Martin, G., Staels, B., & Auwerx, J. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00006 · Cited by 489
Self-citationMultiple signals converging on NF-κB
Mercurio, F., & Manning, A. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80030-1 · Cited by 473
Baud, V., Liu, Z.-G., Bennett, B., Suzuki, N., Xia, Y., & Karin, M. (1999) · Genes & Development · doi:10.1101/gad.13.10.1297 · Cited by 464
Wallace, J. L., MacNaughton, W. K., Morris, G. P., & Beck, P. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90760-9 · Cited by 435
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
Neurath, M. F., Fuss, I., Pasparakis, M., Alexopoulou, L., Haralambous, S., Meyer zum Büschenfelde, K., Strober, W., & Kollias, G. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270722 · Cited by 413
Darnay, B. G., Ni, J., Moore, P. A., & Aggarwal, B. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7724 · Cited by 399
MEKK1 activates both IκB kinase α and IκB kinase β
Lee, F. S., Peters, R. T., Dang, L. C., & Maniatis, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9319 · Cited by 384
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease
Desreumaux, P., Ernst, O., Geboes, K., Gambiez, L., Berrebi, D., Müller-Alouf, H., Hafraoui, S., Emilie, D., Ectors, N., Peuchmaur, M., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70552-4 · Cited by 351
Self-citationCatalysis by a Multiprotein IκB Kinase Complex
Maniatis, T. (1997) · Science · doi:10.1126/science.278.5339.818 · Cited by 254
Ameho, C. K., Adjei, A. A., Harrison, E. K., Takeshita, K., Morioka, T., Arakaki, Y., Ito, E., Suzuki, I., Kulkarni, A. D., Kawajiri, A., et al. (1997) · Gut · doi:10.1136/gut.41.4.487 · Cited by 234
Schoonjans, K., & Auwerx, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90002-3 · Cited by 232
Self-citationDistinct cytokine patterns in early and chronic ileal lesions of Crohn's disease
Desreumaux, P., Brandt, E., Gambiez, L., Emilie, D., Geboes, K., Klein, O., Ectors, N., Cortot, A., Capron, M., & Colombel, J. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70116-1 · Cited by 221
Self-citationJNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action?
Karin, M., & Delhase, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9067 · Cited by 214
MEK Kinase Is Involved in Tumor Necrosis Factor α-Induced NF-κB Activation and Degradation of IκB-α
Hirano, M., Osada, S.-I., Aoki, T., Hirai, S.-I., Hosaka, M., Inoue, J.-I., & Ohno, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13234 · Cited by 201
Gelman, L., Fruchart, J.-C., & Auwerx, J. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050345 · Cited by 199
Self-citationSchwenger, P., Alpert, D., Skolnik, E. Y., & Vilček, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.78 · Cited by 197
Lefebvre, M., Paulweber, B., Fajas, L., Woods, J., McCrary, C., Colombel, J., Najib, J., Fruchart, J., Datz, C., Vidal, H., et al. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1620331 · Cited by 167
Self-citationMeyer, C. F., Wang, X., Chang, C., Templeton, D., & Tan, T.-H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8971 · Cited by 166
Wang, Y., Seibenhener, M. L., Vandenplas, M. L., & Wooten, M. W. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990201)55:3<293::aid-jnr4>3.0.co;2-9 · Cited by 152
The mechanism of altered neural function in a rat model of acute colitis
Jacobson, K., McHugh, K., & Collins, S. M. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70230-0 · Cited by 112
Thome, M., Martinon, F., Hofmann, K., Rubio, V., Steiner, V., Schneider, P., Mattmann, C., & Tschopp, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.9962 · Cited by 100
Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats
Palmen, M. J. H. J., Dijkstra, C. D., van der Ende, M. B., Peña, A. S., & van Rees, E. P. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb08363.x · Cited by 99
Alpert, D. R., Schwenger, P., Han, J., & Vilček, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22176 · Cited by 98
Englaro, W., Bahadoran, P., Bertolotto, C., Buscà, R., Dérijard, B., Livolsi, A., Peyron, J., Ortonne, J. P., & Ballotti, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202446 · Cited by 81
Self-citationVanadate Induction of NF-κB Involves IκB Kinase β and SAPK/ERK Kinase 1 in Macrophages
Chen, F., Demers, L. M., Vallyathan, V., Ding, M., Lu, Y., Castranova, V., & Shi, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20307 · Cited by 71
Carpentier, I., Declercq, W., Malinin, N. L., Wallach, D., Fiers, W., & Beyaert, R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00226-9 · Cited by 66
de Blaauw, I., Deutz, N. E. P., van der Hulst, R. R. W. J., & MEYENFELDT, M. F. V. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70226-9 · Cited by 65
Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis
Palmen, M. J. H. J., Dieleman, L. A., van der Ende, M. B., et al. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb05537.x · Cited by 38
Ma, W. Y., Huang, C., & Dong, Z. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.3.565 · Cited by 32
Dykens, J. A. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850171918 · Cited by 21
Cited by
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Calder, P. C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04374.x · Cited by 1,347
Varga, T., Czimmerer, Z., & Nagy, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.014 · Cited by 933
Emerging roles of PPARS in inflammation and immunity
Daynes, R. A., & Jones, D. C. (2002) · Nature Reviews Immunology · doi:10.1038/nri912 · Cited by 919
War and peace at mucosal surfaces
Sansonetti, P. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1499 · Cited by 679
Metadata
- Authors
- Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M., Englaro, W., Schoonjans, K., Derijard, B., Desvergne, B., Wahli, W., Chambon, P., Leibowitz, M. D., Colombel, J.-F., & Auwerx, J.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-04-02
- Volume
- 193
- Issue
- 7
- Pages
- 827-838
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2157393124
- Cited by
- 457
- References
- 46
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.